The development of materials toward ppb-level nitric oxide (NO) sensing at room temperature remains in high demand for the monitoring of respiratory inflammatory diseases. In order to find an iron-containing molecule without steric hindrance to combine with graphene for room temperature NO gas sensing, here a supramolecular assembly of ferrocene (Fc) and reduced graphene oxide (rGO) was designed and prepared for NO sensing. The assembly of Fc/rGO was characterized using FT-IR, TEM, and XPS measurements. The Fc/rGO-based sensors exhibited superior NO sensing properties at room temperature including high response (R_a/R_g = 1.73, 1 ppm), high selectivity against other exhaled gases, reliable repeatability and stability (less than 4 % decrease after 40 days). A practical limit of detection (LOD) of 200 ppb was achieved. The theoretical simulation demonstrates that ferrocene is assembled via π-π interaction with rGO in edge-to-face configuration which provides relatively lower energy than face-to-face configuration does for the whole assembly. It was first verified that the enhanced adsorption capacity and the charge transfer between NO and Fc/rGO would result in improvement of the assembly's sensitivity toward NO after ferrocene was assembled with graphene. This work provides a fresh approach of anchoring iron on graphene for gas sensing via supramolecular methods.

To develop multifunctional small-molecule prodrugs is highly desirable for cancer treatment but remains challenging in intrinsic traceability. As an acid-cleavable linkage, a Schiff bases benefiting from its distinctive fluorescence quenching ability was selected to prepare a small-molecule prodrug with cancer-targeted and self-indicating. In this study, we designed and developed a multifunctional self-assembled nanobomb of amphiphilic TPE-Lenalidomide prodrug, which comprises a hydrophobic aggregation-induced emission (AIE) probe 4-(1,2,2-triphenylvinyl)benzaldehyde (TPE-CHO) and a hydrophilic anticancer drug Lenalidomide via a Schiff base linkage. We investigated the synergistic effect of d-PET and C═N isomerization which would keep the fluorescence of TPE-Lenalidomide in the “always off” state by density functional theory (DFT) calculation. Once reaching the pathological site, such a vesicular nanobomb of TPE-Lenalidomide will be acidolyzed to release the AIE probe and Lenalidomide molecules simultaneously, consequently realizing high-efficiency effects of tumor imaging and cancer therapy (cell viability: normal cell L929, ∼79.49%; cancer cell 4T1, ∼27.08%; p = 0.000118). This work may pave an avenue to prepare small-molecule prodrugs for tumor-targeted diagnosis and cancer therapy.